Introduction

Golgi Fragmentation by Mitotic Extract
Eukaryotic cells undergo extensive changes in their inin a Permeabilized Cell System tracellular architecture and physiology upon entry into NRK cells grown on Pronectin F coated glass coverslips mitosis. Some of the notable changes in mammalian were permeabilized with digitonin, a detergent that specells include condensation of DNA, fragmentation of the cifically binds to cholesterol (Eilenberg et al., 1989) . This nuclear envelope and Golgi complex, depolymerization treatment resulted in preferential permeabilization of the of cytoplasmic microtubules, and a block in endocytic plasma membrane due to its proportionally higher choand exocytic protein transport (for a review, see Warren, lesterol content while intracellular organelles remained 1993). In nondividing mammalian cells, the Golgi comrelatively intact. We routinely observed permeabilization plex, comprised of stacks of cisternae, is anchored to of greater than 90% of the cells by this method. Permethe pericentriolar region through association with the abilized cells were washed with buffer containing 1M KCl microtubule organizing center (Rogalski and Singer, to remove cytosolic and peripheral membrane proteins.
1984). When cells enter mitosis, Golgi stacks fragment
The high salt wash is essential for Golgi fragmentation into small vesicles, clusters of vesicles, and tubular eleby mitotic extract. Subsequently, salt-washed permements (Lucocq et al., 1987) . In postmitotic cells, these abilized cells were incubated with mitotic extract and fragments reassemble to form a perinuclear Golgi coman ATP-regenerating system at 32ЊC for 1 hr. The extent plex in each daughter cell (Lucocq et al., 1989) . This of Golgi fragmentation was then determined by fixing process of vesiculation followed by reassembly has and processing cells for immunofluorescence microsbeen proposed to ensure partitioning of Golgi memcopy (IF) using an antibody to the Golgi-specific protein, branes into daughter cells during cell division (Warren, Mannosidase II (Man II) . Figure 1A (no extract) shows 1993). Our aim is to address the mechanisms by which the normal, ribbon-like perinuclear appearance of the the organization of Golgi membranes is regulated during Golgi complex in salt-washed, permeabilized cells. Incuthe cell cycle.
bation of such permeabilized cells with interphase exEntry of cells into mitosis requires formation of an tract (at the same protein concentration as mitotic exactive complex between p34 cdc2 kinase and cyclins at tract) did not significantly perturb the organization of G2-M boundary ). While we have come a Golgi membranes. However, the Golgi complex aplong way in our understanding of the mechanisms by peared less ribbon-like and more pericentriolar in these which the activity of p34 cdc2 kinase is regulated, it is cells. In contrast, incubation of permeabilized cells with still not clear how p34 cdc2 kinase induces the profound mitotic extract caused extensive fragmentation of the Golgi complex. Staining with a cis Golgi marker such as giantin, and trans and trans Golgi network (TGN) ‡ To whom correspondence should be addressed. markers, sialyltransferase and TGN-38, respectively, revealed that these markers also appeared fragmented under these conditions (data not shown). On analyzing 200 cells on duplicate coverslips, Golgi fragmentation was observed in greater than 90% of the cells ( Figure  1B ). Golgi membranes did not fragment when permeabilized cells were incubated with mitotic extract on ice or when the cellular ATP pool was depleted (data not sporine fragmented the Golgi, while in the presence of (B) Percentage of cells with fragmented Golgi, after incubation with the inhibitor, the Golgi complex remained intact and interphase extract (I) and mitotic extract (M). The change in organization of Golgi membranes, from intact perinuclear Golgi to punctate perinuclear ( Figure 2B assaying for phosphorylation of histone H1, which is a and assayed for H1 kinase activity. p34 cdc2 peaks in fractions 5-6, measure of p34 cdc2 kinase activity. In Figure 3A in Figure 3B . This activity was lost upon treatment of Golgi fragmentation, and 65% in the case of FT alone. Pools A, B, or C do not show any significant fragmentation activity and FT ϩ S depleted extract with staurosporine (data not shown).
inhibits Golgi fragmentation activity.
These results show that once cells have entered mitosis through activation of p34 cdc2 kinase, extracts from such cells can be depleted of p34 cdc2 kinase without affecting A (bound fractions 1-3), pool B (fractions 4-8, p34
cdc2 -Golgi fragmentation activity.
containing pool), and pool C (fractions 9-12) did not show any fragmentation activity individually or when mixed with each other. No significant increase in fragSeparation of the Golgi Fragmenting Kinase from p34 cdc2 mentation activity of flowthrough was observed when it was mixed with any of the eluate pools, A, B, or C (data Since our results indicate that the continued presence of p34 cdc2 is not required for Golgi breakdown, we denot shown). These results indicate that flowthrough contains the necessary components for Golgi fragmentacided to fractionate mitotic extract to obtain a kinase(s) activity that is separable from p34 cdc2 . Mitotic extract tion. When flowthrough was incubated with staurosporine, Golgi fragmentation was inhibited, strongly was fractionated on a phosphocellulose (p11) column. Flowthrough from the column was collected and the implicating a kinase(s) in this process ( Figure 4B ). column eluted with increasing salt concentration. Each column fraction was assayed for H1 kinase activity and Identification of the Mitotic Kinase(s) Involved in Golgi Fragmentation immunoblotted with anti p34 cdc2 antibody. As seen in Figure 4A , p34 cdc2 was found in fractions 4-8, with the We first sought to test whether the Golgi fragmenting kinase can be categorized to a general class of kinases. highest amounts in fractions 5-6. H1 kinase activity, a measure of p34 cdc2 kinase activity, had the same distribuIn order to identify the class to which the Golgi disassembly kinase(s) belongs, we have made use of various tion. Each of these fractions or pools was tested for Golgi breakdown activity ( Figure 4B ). Golgi fragmentaspecific inhibitors that have been developed for different kinases. Olomoucine is a specific inhibitor of cyclintion activity was observed in 70% of cells when flowthrough and eluate from the column were mixed. dependent kinases, especially of cyclin A-dependent kinases. Mitotic extract after preincubation with oloWhen flowthrough (devoid of active p34 cdc2 ) was used, Golgi breakdown was observed in 65% of cells. Pool moucine was added to salt-washed, semiintact cells. the kinase(s) responsible for Golgi fragmentation does not belong to PKA or PKC families.
Golgi Fragmenting Kinase in the Mitotic Extract Is a MAP Kinase Kinase
Mitogen-activated protein kinases (MAPKs), also called extracellular signal-regulated kinases (ERKs), are a family of protein kinases that function in a wide variety of intracellular signal transduction pathways (Ahn et al., 1993; Marshall, 1994; . MAPK activation requires concomitant phosphorylation on specific Thr and Tyr residues by MAP kinase kinase (MAPKK or MEK; Zheng and Guan, 1993) . MEK, in turn, is a substrate for phosphorylation by several kinases such as Raf, Mos, and MEKK (Dent et al., 1992; LangeCarter et al., 1993; Posada et al., 1993) . The four major pathways leading to MAPK activation are the p44/p42, the SEK-SAPK/JNK-c-Jun, the p38 (HOG), and BMK1/ ERK5 pathways. Each of these is activated by largely distinct stimuli.
To test if a MAPK in the mitotic extract is involved in Golgi fragmentation, the extract was preincubated with different concentrations of PD098059 (PD), a highly specific inhibitor of MEK1 (Alessi et al., 1995; Dudley et al., 1995) . This noncompetitive inhibitor blocks activation of MEK1 by Raf or MEKK. Treatment of mitotic extract with increasing concentrations of PD resulted in increased comparable to untreated mitotic extract, indicating that mitotic extract with either no inhibitor (ME), with olomoucine (ME ϩ p34 cdc2 levels remained unaltered under these conditions OLO), calphostin C (ME ϩ CAL C), or PKI (ME ϩ PKI). These kinase (data not shown). On the other hand, if cells were treated inhibitors do not inhibit Golgi fragmentation.
with PD for 45 min at 37ЊC followed by removal of the activity of MEK1 in mitotic extract, we carried out the following experiment. A routine procedure to test the Golgi fragmentation was monitored by staining with an activity of ERK1 and ERK2 (substrates of MEK1) was antibody to Man II, and the ability of cytosol to phosphorperformed by monitoring specific phosphorylation of ylate H1 was also measured. While olomoucine inhibited myelin basic protein (MBP) in an immune complex assay H1 kinase activity, the Golgi complex remained intact (Boulton and Cobb, 1991) . Mitotic extract was incubated in greater than 80% of the cells ( Figure 5A ). These results with increasing concentration of PD, and this reaction suggest that the Golgi fragmenting kinase is distinct mixture was used in parallel to monitor Golgi fragmentafrom a cyclin-dependent kinase (especially cyclin A).
tion and MEK activity. The effect of PD on MEK activity Treatment of mitotic extract with calphostin C, a specific was monitored by the following scheme. PD-treated or inhibitor of protein kinase C (PKC), had a moderate effect untreated mitotic extract was incubated with anti-MEK1 on Golgi fragmentation by the extract as shown in Figure  antibody bound to protein G Sepharose. The immu-5A. H1 kinase activity of calphostin C-treated mitotic noabsorbed MEK1 was incubated with unphosphoryextract was similar to the noninhibitor-treated extract. lated ERK2 (bacterially expressed) for 30 min and 30ЊC. When mitotic extract was treated with PKI, a specific The beads were removed by centrifugation, and the inhibitor of protein kinase A (PKA), fragmentation of the supernatant containing ERK2 was incubated with MBP, Golgi was observed in 90% of cells. Although PKI had ␥-( 32 P) ATP for 30 min at 30ЊC. The reaction was stopped little effect on Golgi breakdown, it lowered H1 kinase by adding Laemmli buffer, analyzed by SDS-PAGE, and activity of the mitotic extract as compared to the extract quantitated using a phosphorimager. The results of such without the inhibitor. Both PKI and calphostin C inhibited an experiment are shown in Figure 5C . The extent of activities of PKA and PKC, respectively, in other assays phosphorylation of MBP by ERK2 as a result of activathat were carried out to show that the inhibitors are tion by MEK1 from untreated mitotic extract was assumed as 100%. At 25 M PD, MEK1 was 78% active; functional (data not shown). These results indicate that data shown is an average of three independent experiments. The bottom panel shows that under identical conditions, a control protein p97 was not depleted. The average extent of MEK1 depletion obtained by densitometric scanning of three separate blots was MEK1 depletion inhibits Golgi fragmentation ( Figure 6B ). histogram in Figure 6B ). The loss of Golgi fragmentation upon depletion of MEK1 and its restoration upon addition of MEK1 is a convincing demonstration of the essenat 50 M, 38% active; and at 75 M, 35% active. The parallel experiment revealed that at 25 M PD, Golgi tial role of MEK1 in Golgi breakdown. fragmentation was observed in 75%; at 50 M PD, in 35%; and at 75 M PD, in 33% of cells. These results ERK1 and ERK2 in the Mitotic Extract Are Not Required for Golgi Fragmentation demonstrate that PD inhibits MEK1 activity in the mitotic extract, and this correlates with inhibition of Golgi fragThe only known targets for MEK1 to date are ERK1 and ERK2 (Seger et al., 1992) . To test if ERK2 in the mitotic mentation.
extract is necessary for Golgi fragmentation, mitotic extract was depleted of ERK2 using an anti ERK2 antibody Depletion of MEK 1 Prevents Golgi Fragmentation by Mitotic Extract conjugated to protein G Sepharose. ERK2 was almost completely depleted from mitotic extract after 3 hr of Having shown that PD inhibits the activity of MEK1 and Golgi fragmentation by mitotic extract, we further tested incubation ( Figure 7A , top panel). The bottom panel indicates that a control protein, p97, was not depleted under the requirement of MEK1 in the breakdown process. An antibody recognizing the N-terminal domain of MEK1 identical conditions. The mock-and ERK2-depleted mitotic extract were tested in the Golgi breakdown assay. was conjugated to protein G Sepharose beads and employed for depleting MEK1 from mitotic extract. The top As shown in Figure 7B , depletion of ERK2 had no effect on Golgi fragmentation. ERK1 activity was retained in panel of Figure 6A is a Western blot of mock (M)-and MEK1-depleted (D) extract for a single experiment while MEK1-inhibited mitotic extract, indicating that ERK1 in the mitotic extract is not required either for Golgi fragthe bottom panel shows a control blot with anti p97 antibody. Greater than 90% depletion of MEK1 was mentation (data not shown). These results demonstrate that the known cytoplasmic substrates of MEK1 (i.e., achieved in 3 hr in this representative experiment. The average extent of MEK1 depletion for three different ERK1 and ERK2) in the mitotic extract are not essential for Golgi fragmentation. experiments was 80%. Depletion could not be carried out beyond 3 hr because there was increasing loss of fragmentation activity of mock-depleted extract due to Is the Downstream Target of MEK1 in Golgi Fragmentation an ERK? nonspecific loss of essential components on protein G Sepharose beads. The mock-and MEK1-depleted
We have shown that ERK-depleted mitotic extract is capable of fragmenting the Golgi. However, MEKmitotic extracts, when tested in the assay, revealed that
Do Golgi Membranes Contain an ERK?
To test the localization of ERK in semiintact cells, we carried out immunofluorescence with a broadly reactive ERK (rabbit) antibody. Permeabilized NRK cells were washed with 1 M KCl, fixed and stained with a Golgispecific marker, Giantin, and the anti-ERK antibody. We made use of Giantin (mouse antibody) as a Golgi marker, instead of Man II (rabbit) for double staining of cells. The anti-ERK antibody under these conditions recognized cytoplasmic and nuclear staining predominantly with a faint perinuclear staining. However, when such cells were washed with mild detergent (0.0025% Triton X-100) in a cytoskeletal stabilization buffer, perinuclear staining was prominent ( Figure 8B ). This staining completely colocalized with the staining of Golgi-specific Giantin, indicating that an ERK is tightly associated (resistant to 1 M KCl and up to 0.01% detergent) with Golgi membranes. The ERK antibody showed additional nuclear and cytoskeletal staining as expected.
To further demonstrate the presence of an ERK on Golgi membranes, we carried out the following experiment. NRK cells were treated with a microtubule depolymerizing agent, nocodazole, for a short period of time. This treatment resulted in dispersal of Golgi stacks from the perinuclear region throughout the cytoplasm (Rogalski and Singer, 1984) . Nocodazole-treated cells were washed to remove the drug, permeabilized, and washed with salt and mild detergent. The cells were fixed and processed for IF microscopy using anti-ERK and Giantin antibodies. As seen in Figure 9B , there was complete an ATP-regenerating system at 32ЊC for 1 hr. Under such conditions, Golgi membranes underwent further depleted extract, which contains activated ERKs, is unfragmentation into small punctate structures throughout able to fragment the Golgi. We reason that the target of the cytoplasm as shown in Figure 9A . This fragmentation MEK must be in the recipient semiintact, salt-washed was also inhibited by treatment of mitotic extract with cells. If the downstream target for MEK1 is associated PD (data not shown). This finding further confirms that with the cells, then incubating permeabilized cells with the downstream target of MEK1 remains associated with excess inactivated ERK should inhibit fragmentation by dispersed Golgi stacks. In addition, this experiment competing with the bona fide MEK1 target. On the other shows that perinuclear location of Golgi stacks is not hand, activated ERK should have no effect on the fragnecessary for its fragmentation during mitosis. mentation process. To test this possibility, the following experiment was carried out. Permeabilized, salt-washed cells were preincubated with increasing concentrations Discussion of inactivated ERK2 (incapable of phosphorylating MBP) or activated ERK2 (capable of phosphorylating MBP).
Fragmentation of Golgi Membranes by Mitotic Extract in Permeabilized Cells
These cells were incubated with mitotic extract and an ATP-regeneration system for 1 hr at 32ЊC. Cells were
We have established conditions that cause extensive fragmentation of the Golgi complex by mitotic extract fixed and visualized by fluorescence microscopy using the Man II antibody. The results are shown in Figure 8A .
in permeabilized cells. Visualization of Golgi membranes with antibodies to integral membrane proteins revealed Increasing concentrations of inactivated ERK2 inhibited Golgi fragmentation while activated ERK2, even at the extensive fragmentation of the complex into punctate structures that were found dispersed in the cytoplasm. highest concentration, did not. This experiment reinforces our findings that MEK1 in the mitotic extract and This change in the organization of Golgi membranes was easy to score at the light microscopy level and ERK in the recipient cell are required for Golgi fragmentation.
provided a convenient assay to identify the molecular
MEK Is the Key Kinase in the Golgi Fragmentation Pathway
It has been shown that endocytic vesicle fusion in vitro is inhibited by p34 cdc2 kinase (Tuomikoski et al., 1989) . Intra-Golgi transport is also inhibited by p34 cdc2 and by another downstream kinase yet to be identified (Stuart et al., 1993) . In addition, it has been shown that p34 cdc2 is required for Golgi breakdown using purified Golgi stacks and cytosol generated from mitotic Hela cells (Misteli and Warren, 1994) . However, these experiments do not distinguish whether a direct action of p34 cdc2 is necessary or if a downstream kinase once activated by it can then directly cause Golgi breakdown in the absence of p34 cdc2 . We show that p34 cdc2 kinase-depleted mitotic extract has no effect on Golgi fragmentation, whereas depleting MEK1 is inhibitory. An important clue about the involvement of MEK1 in Golgi fragmentation came from use of the MEK1 inhibitor, PD. We found that treating mitotic extract and not semiintact cells with PD inhibits Golgi fragmentation. The concentration of PD required to inhibit MEK1 activation, as measured in vitro, correlates with inhibition of Golgi fragmentation activity of PD-treated mitotic extract. While this provides strong evidence for the requirement of MEK1 activation in Golgi fragmentation, the most convincing evidence comes from the finding that mitotic extract depleted of MEK1 is inactive in Golgi fragmentation. Addition of constitutively active MEK1 restores Golgi fragmentation activity to MEK1-depleted extract.
These results then raise the obvious question-what vincing is our finding that depletion of ERK2 from mitotic dispersed in punctate dots (mitotic extract); discrete stacks are cytosol has no effect on its ability to fragment Golgi cence microscopy reveals that an ERK is tightly associated with Golgi membranes. It has been shown that ERK associates with the cytoskeleton (Reszka et al., 1995; Morishima-Kawashima and Kosik, 1996) . This cytoskelcomponents involved. Fragmentation was observed etal fraction includes microtubules and a detergentonly when semiintact cells were washed with a high resistant membrane fraction. We propose that a tightly ionic strength buffer. High salt wash most likely removed Golgi-associated ERK confers specificity to the effect inhibitors of Golgi fragmentation by mitotic extract. The of activated MEK1 in Golgi breakdown during mitosis. major findings that emerge from our study are: (1) p34 cdc2 This would serve as an attractive means for phosphorykinase, the key kinase for onset of M phase, can be lation and local regulation of Golgi proteins that would depleted from mitotic extract without affecting Golgi eventually lead to fragmentation of the organelle. fragmentation activity; (2) MEK1 in the mitotic extract is Interestingly, we find that mitotic extract can fragment involved in Golgi fragmentation; (3) ERK1 and ERK2, the Golgi stacks when they are perinuclear or dispersed in downstream targets of MEK1 in the mitotic extract, are the cytoplasm. In addition to strengthening our proposal not required for Golgi fragmentation, and (4) the downthat the Golgi-associated ERK may be the direct target stream target of MEK1, however, is an ERK, and we for activated MEK1, these results shed light upon anshow the presence of a tightly associated ERK on Golgi other important aspect about the fate of Golgi membranes during mitosis. As mentioned in the Introduction, membranes. fragmentation has been proposed to ensure partitioning mitosis, and Golgi fragmentation by ␤␥ in nondividing cells may converge on a common Golgi-associated kiof a single-copy organelle like the Golgi into two daughter cells. However, this is not a universal process. For nase or its substrate. The identification of MEK1 in Golgi fragmentation is a significant step toward delineating example, in the budding yeast Saccharomyces cerevisiae, the Golgi membranes in the new bud are acquired the signaling pathways involved in regulating Golgi structure during the cell cycle. by migration of intact individual units from the mother cell (Preuss et al., 1992) . Golgi stacks remain intact in
Experimental Procedures
plant cells during cell division (Hirose and Komamine, 1989) . We have recently shown that Golgi membranes MEKR4F), and inactivated ERK2 were kind gifts from Dr. James Ferrell (Stanford). The MEK1 antibody used for immunoblotting was a gift from Dr. Deborah Spector (University of California, San Diego).
The Signaling Cascade Involved
The MAPK antibody (ab-1) used for blotting was purchased from in Golgi Fragmentation the oocyte cell cycle and induces interphase-metaphase transition of microtubules (Gotoh et al., 1991) .
Preparation of Mitotic and Interphase Extracts
These studies also show that an ERK activator (MEK)
The extracts were prepared by the method of Nakagawa (Nakagawa is one of the intermediates between p34 cdc2 and ERK et al., 1989) . NRK cells grown attached on 20 cm petri dishes were . Recent studies in Xenopus ex- in these systems (Minshull et al., 1994; Min Wang et al., and were easily detached from the petri dishes by a "shake off" 1997). Therefore, the exact role of ERKs depends on the ulate that MEK mediated Golgi fragmentation during kinase A inhibitor (PKI). After incubation for 10 min at room temperaAssay of Enzymatic Activity of MEK1 PD treated or untreated mitotic extract was incubated with antiture, the reactions were terminated by the addition of Laemmli buffer. Samples were electrophoresed on a 12% polyacrylamide MEK1 antibody bound to protein G Sepharose. The immunoabsorbed MEK1 was incubated with unphosphorylated ERK2 (0.4 g/ gel, the gel was dried, and 32 P incorporation was quantitated by densitometry. We routinely observed a 35 to 40-fold increase of H1 30 l reaction) for 30 min and 30ЊC. The beads were removed by centrifugation, and the supernatant containing ERK2 was incubated kinase activity in mitotic over interphase extract.
with MBP, ␥-( 32 P) ATP for 30 min at 30ЊC. The reaction was stopped by adding Laemmli buffer, analyzed by SDS-PAGE, and quantified Cell Permeabilization using a phosphoimager. Activated ERK2 (at the same concentration NRK cells were grown to 60% confluency on Pronectin F-coated as inactivated) was used as a positive control in the phosphorylation glass coverslips and incubated with 2 mM thymidine for 8-10 hr at reaction. The kinase buffer used in this reaction was 30 mM HEPES 37ЊC. These cells were washed at room temperature in KHM buffer (pH 7.2), 10 mM MgCl2, 1 mM DTT, 5 mM benzamidine, 15 mg (25 mM HEPES-KOH [pH 7.2], 125 mM potassium acetate, 2.5 mM MBP/30 l, 50 M ATP, ␥-( 32 P) ATP 30 Ci/ 30 l. magnesium acetate) in 24-well plates and shifted to ice for 2 min in cold KHM buffer. Cells were then permeabilized with 30 g/ml digitonin in KHM buffer and washed with 1 M KCl-KHM, followed
Depletion of MEK1 and ERK2 from Mitotic Extract by KHM. The cells were then inverted on a 50 l reaction mixture MEK1 was depleted using rabbit antibody 662 coupled to protein and incubated at 32ЊC for 1 hr. The reaction mix contained KHM, G Sepharose beads overnight. ERK2 was depleted by using rabbit mitotic extract (final concentration 7 mg/ml), and an ATP-regeneraantibody TR10 conjugated to protein G Sepharose. Mock beads tion system (final concentration 0.5 mM ATP, 0.3 mM UTP, 10 mM did not contain antibody. Antibody-coupled and mock beads were creatine phosphate, and 12 IU/ml creatine kinase).
incubated with mitotic extract for 90 min with gentle shaking at 4ЊC. The beads were centrifuged, and supernatant was added to fresh Immunofluorescence Microscopy beads and incubated for an additional 90 min. The extent of depleCells were fixed and stained as described before (Acharya et al., tion was assessed by SDS-PAGE of mock and depleted extracts 1995a, 1995b). In some cases ( Figures 8B and 9B ), cells were first followed by immunoblotting. Constitutive MEK1 (his-MEKR4F) was washed on ice in cytoskeletal stabilization buffer (10 mM PIPES [pH human MEK1 expressed in bacteria and greater than 90% pure. It 7.5], 5 mM EGTA, 15 mM KCl, 2 mM MgCl 2 , 1 mM DTT, and 0.2 mM was used at a final concentration of 0.5 g in a 50 l reaction mix PMSF) for 2 min followed by extraction for 2 min on ice with 0.0025% from a stock of 0.3 mg/ml. Triton X-100 in the cytoskeletal stabilization buffer. The cells were again washed with cytoskeletal stabilization buffer for 1 min and Preincubation of Semiintact, Salt-Washed Cells then fixed in 4% formaldehyde. The TR2 (anti-ERK) antibody was with Inactive or Activated ERK2 used at 1:100 dilution.
Semiintact, salt-washed cells were incubated with different concentrations of ERK2 for 10 min at 32ЊC. These cells were then incubated Incubation of Permeabilized Cells with Protein with mitotic extract and an ATP-regenerating system for 1 hr at Kinase Inhibitors 32ЊC. Inactivated ERK2 (0.4 mg/ml) was His 6 tagged, bacterially Mitotic extract was pretreated with specific inhibitors for 10 min at expressed, and purified. 32ЊC. This mixture was then added to semiintact, salt-washed cells and incubated at 32ЊC for 1 hr. Staurosporine was used at 10 M Nocodazole Treatment of Intact Cells from a stock of 1 mM; calphostin C was used at 500 nM from a Intact cells were incubated with 25 g/ml nocodazole in media stock of 10 mM. PKI was used at 50 M final concentration from a containing 25 mM HEPES (pH 7.4) for 2 hr at 37ЊC. These cells were stock of 500 M. All stocks were made in DMSO. PD was used at either immediately fixed or permeabilized and treated with mitotic 25, 50, and 75 M from a stock of 20 mM in DMSO. Mitotic extract extract. containing a ATP-regeneration system was incubated with different concentrations of PD for 10 min at 32ЊC. This mixture was then Acknowledgments added to semiintact cells, and the assay was carried out for 1 hr at 32ЊC. For pretreatment of cells with PD, intact cells were preincuWe are indebted to Drs. James Ferrell and Ramesh Bhatt for their bated with 75 M PD for 45 min at 37ЊC. These cells were then generous supply of MEK and MAPK reagents. We gratefully acpermeabilized as described before.
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Fractionation of Mitotic Cytosol on a P11
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